Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Trillium Therapeutics Inc.
T.TRIL
Healthcare
Biotechnology
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TRIL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
(93)
•••
birch1
X
View Profile
View Bullboard History
Comment by
birch1
on Feb 28, 2020 2:19pm
RE:IS SOMETHING UP BEHIND THE SCENES?
you saw the nr. no news. down we go.
(18)
•••
Stockemups
X
View Profile
View Bullboard History
Post by
Stockemups
on Feb 28, 2020 12:20pm
IS SOMETHING UP BEHIND THE SCENES?
This is a massive run up.
QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp
posted Nov 25, 2024 9:00am by
Q Precious & Battery Metals Corp.
-
|
The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more
(100)
•••
CleverInvestor2
X
View Profile
View Bullboard History
Post by
CleverInvestor2
on Feb 28, 2020 11:08am
Trillium Therapeutics a $50 Stock?
The fool (Motley Fool) has released a new article about Trillium and Forty Seven. Nothing new but a nice recap on Trilliums potential. Yes, we are not as ahead as Forty Seven but, our medication is
...more
(100)
•••
CleverInvestor2
X
View Profile
View Bullboard History
Comment by
CleverInvestor2
on Feb 28, 2020 10:11am
RE:Today we set up a new 52week high?
I'm surprised we haven't been halted yet. We're at 52week highs and up 60+% this morning.
(100)
•••
CleverInvestor2
X
View Profile
View Bullboard History
Post by
CleverInvestor2
on Feb 28, 2020 9:53am
Today we set up a new 52week high?
We were very close this morning, hit about $4.77US.... still trading above $4.50US. Lets see if we can get to $5US today.
(100)
•••
CleverInvestor2
X
View Profile
View Bullboard History
Comment by
CleverInvestor2
on Feb 27, 2020 11:44pm
RE:News
Forty Seven is valued at about 2.3Billion..... Trillium has "much better medicine than our competitors" so..... I understand that Trillium is still in development and proving their drug....
...more
(0)
•••
GriffMac
X
View Profile
View Bullboard History
Post by
GriffMac
on Feb 27, 2020 8:25pm
News
Trillium Therapeutics (NASDAQ:TRIL) has jumped 43.6% postmarket after reports that Gilead Sciences approached Forty Seven (NASDAQ:FTSV) with a takeover offer. Trillium is working on a medicine
...more
(100)
•••
CleverInvestor2
X
View Profile
View Bullboard History
Post by
CleverInvestor2
on Feb 27, 2020 5:07pm
Any news release?
We're up 40+% in after hours trading..... on a terrible day like today... what did I miss?
(100)
•••
CleverInvestor2
X
View Profile
View Bullboard History
Comment by
CleverInvestor2
on Feb 20, 2020 7:39pm
RE:$2.75 USD is price to get in
How's that working out for you? When I look at the charts, it looks like we're going to break through $5US before we go below $2.75. GLTA but my advice is to hold right now. Tomorrow might be
...more
(29)
•••
mingzhu
X
View Profile
View Bullboard History
Post by
mingzhu
on Feb 16, 2020 9:39am
$2.75 USD is price to get in
institutios put that price for financing. retailers should follow. The trend is down for the monment. it may go even under that price in next a couple of months
(100)
•••
CleverInvestor2
X
View Profile
View Bullboard History
Comment by
CleverInvestor2
on Feb 15, 2020 11:27am
RE:Time to get in?
I would wait a few weeks, see which direction the stock trades. You can probably get in for a bit cheaper than current prices. If the stock breaks $4.75 USD I'd buy in right away as it would most
...more
(53)
•••
88guy88
X
View Profile
View Bullboard History
Comment by
88guy88
on Feb 03, 2020 9:14am
RE:RE:RE:RE:The Rockerfeller Family Added More TRIL
good price targets for buying....reasonable....good luck
(93)
•••
birch1
X
View Profile
View Bullboard History
Comment by
birch1
on Feb 02, 2020 9:31pm
RE:RE:RE:The Rockerfeller Family Added More TRIL
I decided to take out because of the financing that nearly results in 200x the float so, yes they have cash, but my guess is in the short term this will go down to at least $3.00 Will buy back
...more
(100)
•••
CleverInvestor2
X
View Profile
View Bullboard History
Comment by
CleverInvestor2
on Jan 31, 2020 10:52pm
RE:RE:The Rockerfeller Family Added More TRIL
That's why I haven't sold my shares yet. The long term gain is worth the short term pain.... and by long term, I mean 1-2 years at most. Our next big NR and Run up should happen in June when
...more
(93)
•••
birch1
X
View Profile
View Bullboard History
Comment by
birch1
on Jan 29, 2020 11:35pm
RE:The Rockerfeller Family Added More TRIL
anyone think this is $15 to $20 in the next 2 months?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario